Koninklijke Philips N.V. Q3 2025 Earnings Recap

Royal Philips reported a strong Q3 2025, driven by an 8% growth in order intake and robust performance across all business segments, particularly Personal Health. The company's adjusted EBITDA margin expanded despite ongoing tariff impacts, reflecting effective cost management and innovation.

Key Takeaways

• Order intake increased by 8%, marking the fourth consecutive quarter of growth, with strong momentum in North America.
• Comparable sales growth improved to 3% year-on-year, supported by solid demand in Personal Health and Connected Care.
• Adjusted EBITDA margin rose by 50 basis points to 12.3%, showcasing the effectiveness of productivity initiatives.
• The company reiterated its full-year comparable sales growth outlook of 1% to 3%, with a projected adjusted EBITDA margin expected at the upper end of the 11.3% to 11.8% range.
• Free cash flow guidance remains stable at between EUR 0.2 billion and EUR 0.4 billion for the full year.